Predicting long-term (≥ 5 years) event-free survival in multiple myeloma patients following planned tandem autotransplants-Reference-Cited by-同舟云学术

Predicting long-term (≥ 5 years) event-free survival in multiple myeloma patients following planned tandem autotransplants

Published:2002-01 Issue:1 Volume:116 Page:211-217
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Tricot Guido,Spencer Trey,Sawyer Jeffrey,Spoon Dan,Desikan Raman,Fassas Athanasios,Badros Ashraf,Zangari Maurizio,Munshi Nikhil,Anaissie Elias,Toor Amir,Barlogie Bart

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2002.03231.x/fullpdf

Reference33 articles.

1. VAD-based regimens as primary treatment for multiple myeloma;Alexanian;American Journal of Hematology,1990

2. VAD chemotherapy as remission induction for multiple myeloma;Anderson;British Journal of Cancer,1995

3. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma;Attal;New England Journal of Medicine,1996

4. Single versus double transplant in myeloma: a randomized trial of the ‘inter groupe français du myélome’ (IFM);Attal;Blood,1999

5. Single versus doubletransplantation in myeloma: a prospective randomized trial of the inter groupe francophone du myelome (IFM);Attal;Blood,2000

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microparticles and PD1 interplay added a prognostic impact in treatment outcomes of patients with multiple myeloma;Scientific Reports;2021-09-03

2. Impact of Pre-transplant and Post-transplant Remission Status of Patients on Survival in Newly Diagnosed Multiple Myeloma;Indian Journal of Hematology and Blood Transfusion;2019-03-04

3. Defining cure in multiple myeloma: a comparative study of outcomes of young individuals with myeloma and curable hematologic malignancies;Blood Cancer Journal;2018-02-28

4. Analysis of long-term survival in multiple myeloma after first-line autologous stem cell transplantation: impact of clinical risk factors and sustained response;Cancer Medicine;2017-12-28

5. Plasma Cell Tumors;Holland‐Frei Cancer Medicine;2017-02-26